Sumitomo Mitsui Trust Group Inc. lessened its stake in shares of FMC Co. (NYSE:FMC - Free Report) by 67.0% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 18,505 shares of the basic materials company's stock after selling 37,564 shares during the quarter. Sumitomo Mitsui Trust Group Inc.'s holdings in FMC were worth $1,220,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Dark Forest Capital Management LP boosted its stake in shares of FMC by 3.1% in the 2nd quarter. Dark Forest Capital Management LP now owns 6,465 shares of the basic materials company's stock valued at $372,000 after purchasing an additional 192 shares during the last quarter. HB Wealth Management LLC increased its holdings in FMC by 3.8% during the second quarter. HB Wealth Management LLC now owns 5,649 shares of the basic materials company's stock worth $325,000 after buying an additional 208 shares during the last quarter. CreativeOne Wealth LLC raised its holdings in shares of FMC by 6.7% in the 1st quarter. CreativeOne Wealth LLC now owns 3,926 shares of the basic materials company's stock valued at $250,000 after purchasing an additional 246 shares during the period. UMB Bank n.a. increased its holdings in shares of FMC by 56.9% in the second quarter. UMB Bank n.a. now owns 678 shares of the basic materials company's stock valued at $39,000 after purchasing an additional 246 shares during the last quarter. Finally, Benjamin Edwards Inc. grew its position in FMC by 24.3% in the second quarter. Benjamin Edwards Inc. now owns 1,326 shares of the basic materials company's stock valued at $76,000 after acquiring an additional 259 shares during the last quarter. Institutional investors and hedge funds own 91.86% of the company's stock.
Insider Activity
In related news, VP Jacqueline Scanlan sold 4,529 shares of the firm's stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $59.67, for a total transaction of $270,245.43. Following the transaction, the vice president now owns 28,649 shares in the company, valued at $1,709,485.83. This trade represents a 13.65 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.85% of the company's stock.
FMC Price Performance
NYSE FMC traded up $1.59 during trading on Wednesday, reaching $57.20. The company's stock had a trading volume of 1,136,919 shares, compared to its average volume of 1,675,036. The firm has a fifty day moving average of $61.91 and a 200 day moving average of $60.89. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.48 and a quick ratio of 1.09. FMC Co. has a one year low of $50.03 and a one year high of $68.72. The stock has a market capitalization of $7.14 billion, a PE ratio of 4.92, a P/E/G ratio of 1.43 and a beta of 0.85.
FMC (NYSE:FMC - Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The basic materials company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.49 by $0.20. FMC had a net margin of 34.93% and a return on equity of 7.68%. The business had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.04 billion. During the same quarter in the previous year, the business posted $0.44 EPS. The company's quarterly revenue was up 8.5% compared to the same quarter last year. Analysts expect that FMC Co. will post 3.35 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on FMC shares. JPMorgan Chase & Co. raised their target price on FMC from $50.00 to $59.00 and gave the company a "neutral" rating in a report on Monday, August 12th. BMO Capital Markets raised their price target on shares of FMC from $60.00 to $65.00 and gave the company a "market perform" rating in a research report on Friday, August 2nd. Barclays increased their price objective on FMC from $62.00 to $65.00 and gave the company an "equal weight" rating in a report on Monday, August 5th. Mizuho upped their target price on shares of FMC from $64.00 to $70.00 and gave the company a "neutral" rating in a research note on Friday, November 1st. Finally, Citigroup initiated coverage on FMC in a report on Wednesday, October 23rd. They issued a "neutral" rating and a $67.00 price objective for the company. One analyst has rated the stock with a sell rating, ten have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $68.00.
Check Out Our Latest Stock Report on FMC
FMC Profile
(
Free Report)
FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that includes insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control.
Further Reading
Before you consider FMC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FMC wasn't on the list.
While FMC currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.